MINISEMINARS stapedectomies in the past were undoubtedly performed on ears with occult third window syndromes. We will present a review of superior SCD and other third window syndromes, with an emphasis on differentiating them from more common otologic diagnoses. Cases will be presented that illustrate how these syndromes should be included in the differential diagnosis of many common otologic presentations. SCD, the most common third window syndrome, will be discussed in detail, including diagnosis and treatment indications, options, and outcomes.
Educational Objectives: 1) Understand how superior semicircular canal dehiscence can present clinically, and become familiar with the diagnosis and management of the disorder. 2) Understand the concept of "third window syndrome" and list the more common causes of it. 3) Learn when to consider third window syndromes within the context of presentations of common otologic disorders.
Pediatric Otolaryngology

Update on Pediatric Vascular Malformations
Gresham T. Richter, MD (moderator); Steven E. Sobol, MD; Ian N. Jacobs, MD; David H. Darrow, MD; Manish N. Patel, MD Program Description: This ASPO-endorsed miniseminar will describe the state-of-the-art approaches to the diagnosis and management of the most common vascular anomalies encountered by the general otolaryngologist. The format will be short presentations by four expert panelists on the alternative approaches to lymphatic malformations of the head and neck region in children and hemangiomas. We will describe the workup, medical management, endoscopic (cold, laser) , and open surgical approaches to lymphatic malformations and hemangiomas of both the upper aero-digestive tract and the external neck. In addition, the panel will include an interventional radiologist to help delineate the approach to sclerotherapy for complex lymphatic malformations and embolization of hemangiomas, including selection criteria. Specific challenging cases will be addressed by the panel. The overall goal of the miniseminar will be to provide the audience with decision-making tools in the management of both common and the most challenging vascular anomalies of the head and neck region in children. In addition, alternative treatment options will be considered at every point. Program Description: Of the approximately 500,000 pediatric adenotonsillectomies (T&A) done annually in the United States, most are performed for sleep disordered breathing (SDB). To date, most studies looking at the efficacy of T&A for SDB have been small prospective uncontrolled trials. The Childhood Adenotonsillectomy Study (CHAT) is an NHLBI-sponsored multisite prospective randomized controlled trial of T&A for pediatric SDB. A total of 464 children with polysomnographically documented mildmoderate SDB were enrolled and randomized to either T&A or watchful waiting for 7 months. At baseline and follow-up visits, physical examination data were collected, as well as a wide variety of information concerning the subjects' neurocognitive and behavioral status, including formal neuropsychological evaluations and validated survey questionnaires. The primary outcome variable was the NEPSY attention and executive function domain. In a lecture format the CHAT study design will be discussed emphasizing the challenges associated with a randomized study involving a surgical intervention in children. Study results will also be presented, including comparisons between the subjects undergoing T&A and controls regarding SDB severity, neurocognitive and behavioral status, and quality-of-life measurements. Participants should gain an understanding of the efficacy of T&A for addressing the morbidity associated with SDB in children.
Educational Objectives: 1) Understand the unique challenges associated with designing and implementing a large multisite randomized controlled study evaluating a surgical intervention in children. 2) Have an evidence-based understanding of the efficacy of adenotonsillectomy in treating mild-moderate OSA in children. 3) Have an evidence based understanding of the efficacy of adenotonsillectomy for addressing the morbidity associated with mild-moderate OSA in children.
Developing Guidelines for Pediatric Unilateral Hearing Loss
Daniel Choo, MD (moderator); Angela P. Black, MD (moderator); Bradley W. Kesser, MD; Drew M. Horlbeck, MD; Jeffery J. Kuhn, MD; Robert C. O'Reilly, MD Program Description: A growing body of evidence indicates that children with unilateral hearing losses (UHL) demonstrate significant deficits or delays in auditory, speech, and language development, as well as academic performance in general. Concurrent with this recognition of the significance of UHL is the emergence of a broad array of novel hearing aid technologies that can
